Clinical Trials Browser

Phase 2 × Lung Diseases × demcizumab × Clear all

NCT02259582 2020-09-09

DENALI

Phase 2 Completed

82 enrolled 10 charts

Carcinoma, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms